Single Maintenance & Reliever Therapy for Asthma: Guideline Toplines
March 02, 2021

For patients with moderate-to-severe persistent asthma, new guidelines from the NAEPP recommend SMART, particularly for patients with a recent disease exacerbation.

Significant Reductions in Exacerbations Seen in Broad Population of Severe Asthma Patients
March 01, 2021

Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.

Expert-guided Online Decision Tool Supports Real-time Treatment Choice for Severe Asthma
March 01, 2021

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.